NDC product
Fetzima
NDC 0456-2212 · Allergan, Inc.
Key facts
| Product NDC | 0456-2212 |
|---|---|
| Proprietary name | Fetzima |
| Nonproprietary name | LEVOMILNACIPRAN HYDROCHLORIDE |
| Substances | LEVOMILNACIPRAN HYDROCHLORIDE |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Allergan, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA204168 |
| Pharmacologic classes | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| Marketing start | Jul 25, 2013 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: